Simplifying Global Compliance
Postmarket Regulations Stricter For Devices Than for Drugs
Devices & Diagnostics Letter
Federal device postmarket authorities are "far more extensive than for prescription drugs," and the FDA and CDRH are using their authorities to maintain continued device safety, Janet Trunzo, vice president of technology and regulatory affairs at AdvaMed, said.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing